Mon, May 10, 2010
Sun, May 9, 2010
Sat, May 8, 2010
Fri, May 7, 2010
Thu, May 6, 2010
Mon, January 11, 2010
Sat, January 9, 2010
Fri, January 8, 2010
Thu, January 7, 2010
Wed, January 6, 2010
Tue, January 5, 2010
Mon, January 4, 2010
[ Mon, Jan 04th 2010 ] - Market Wire
Cordani Becomes CIGNA CEO
Thu, December 31, 2009
[ Thu, Dec 31st 2009 ] - Market Wire
Quit the Board
Wed, December 30, 2009
[ Wed, Dec 30th 2009 ] - Market Wire
Centric Grants Stock Options
Tue, December 29, 2009
Mon, December 28, 2009
Thu, December 24, 2009
Wed, December 23, 2009
Tue, December 22, 2009
Mon, December 21, 2009

Micrus Endovascular to Present at January Investment Conferences


//health-fitness.news-articles.net/content/2010/ .. o-present-at-january-investment-conferences.html
Published in Health and Fitness on Tuesday, January 5th 2010 at 6:46 GMT by Market Wire   Print publication without navigation


SAN JOSE, Calif.--([ BUSINESS WIRE ])--Micrus Endovascular Corporation (NASDAQ:MEND) today announced that senior management will present at two investment conferences in January:

  • Robert Stern, President and Chief Operating Officer, will present at the OneMedForum 2010 Finance Conference on Tuesday, January 12, 2010, at 9:00 a.m. Pacific time (12:00 p.m. Eastern time) at the Sir Francis Drake Hotel in San Francisco; and
  • John Kilcoyne, Chairman and Chief Executive Officer, will present at the 12th Annual Needham Growth Conference on Tuesday, January 12, 2010, at 2:30 p.m. Eastern time (11:30 a.m. Pacific time) at the New York Palace Hotel in New YorkCity.

Live webcasts of these conference presentations will be available via the Internet by visiting the Investor Relations section of Micrus' Web site at [ www.micruscorp.com ]. Archived presentations will be available on the Company's Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant causes of death and disability worldwide. The Micrus product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus' proprietary, three-dimensional microcoils anatomically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires and accessory products used in conjunction with its microcoils. For more information, visit [ www.micruscorp.com ].


Publication Contributing Sources